Sequential serum galactomannan as outcome marker for invasive aspergillosis—An exploratory study from the FungiScope registry

Background: Galactomannan index (GMI) is established as a diagnostic tool for invasive aspergillosis (IA), while its utility in monitoring antifungal treatment (AFT) response and prognostic value remains unclear. This study evaluated the validity of serum GM as a biomarker for AFT monitoring and its...

Full beskrivning

Bibliografiska uppgifter

Huvudupphov:	Christina Többen, Oliver A. Cornely, Carolin S. Joisten, Ertan Sal, José A. Cozzi, Baptiste Hoellinger, Deniz Yilmaz Karapinar, Daniel Richter, Andreas H. Groll, Gustavo-Adolfo Méndez, Jeffrey D. Jenks, Nurettin Erben, Leyre López Soria, Philipp Koehler, Anna Apostolopoulou, Dries Deeren, Rika Draenert, Iker Falces-Romero, Julio Maquera-Afaray, Lisa Meintker, Ruwanthi Kolamunnage-Dona, Danila Seidel, Jannik Stemler
Materialtyp:	Artigo
Språk:	Inglês
Utgiven:	Elsevier 2026-02-01
Serie:	International Journal of Infectious Diseases
Ämnen:	Biomarker Immunocompromised host Treatment monitoring Registry study Invasive aspergillosis Galactomannan assay
Länkar:	http://www.sciencedirect.com/science/article/pii/S1201971225004941
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!